
₹5,662.50 Original price was: ₹5,662.50.₹5,550.00Current price is: ₹5,550.00.
Spexib 150mg Capsule by Arogya delivers moderate-dose therapy for chronic or oncology conditions, ensuring safe and effective treatment outcomes.
| Country of Origin | Switzerland |
|---|---|
| Manufacturer | NOVARTIS INDIA LTD |
| Pack Size | 10 Capsule(s) In A Strip |
| Product Name | SPEXIB 150MG |
| SKU | AROG-SPX150 |
| Salt Composition | CERITINIB |
| Storage | Do not store above 30˚C |
| Strength | 150mg |
Sorafenat 200mg Tablet is an anticancer medicine containing the active ingredient Sorafenib. It belongs to the class of tyrosine kinase inhibitors and is used to treat various advanced cancers. Cancer is a condition in which cells grow uncontrollably and abnormally.
Before starting Sorafenat 200mg Tablet, inform your doctor if you are allergic to Sorafenib or any other ingredients, or if you have heart problems, chest pain, bleeding disorders, high blood pressure, or are planning to undergo surgery. Effective contraception is recommended during treatment and for 6 months after the last dose for women, and 3 months for men.
Serious:
Common:
Q1. Can a diabetic person take Sorafenat 200mg Tablet?
Yes, it can be taken by diabetic individuals, but only under the supervision of a doctor. Dosage may be adjusted based on the patient’s condition.
Q2. What are the conditions under which Sorafenat 200mg Tablet use is prohibited?
It is not recommended for patients allergic to any ingredient, those with squamous cell lung cancer, or those taking carboplatin and paclitaxel.
Q3. When should I stop taking Sorafenat 200mg Tablet?
Discontinue if major adverse effects severely impair quality of life, or as instructed by your physician. Otherwise, continue until your doctor advises stopping.
Q4. What class of medication is Sorafenat 200mg Tablet?
It belongs to anti-tumor medicines and tyrosine kinase inhibitors.
Q5. Can Sorafenat 200mg Tablet be used during pregnancy?
No, it may harm the unborn baby. Use effective contraception during treatment and for at least six months after the final dose.
Arogya’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Arogya. Our mission is to support, not replace, the doctor-patient relationship.


